[1] 许睿玮, 严卫丽.原发性高血压全基因组关联研究进展[J].遗传, 2012(7):2-18.[2] Rosskopf D, Schurks M, Rimmbach C, et al.Genetics of arterial hypertension and hypotension[J].Naunyn-Schmiedeberg's Arch Pharmacol, 2007, 374(5/6):429-469.[3] Weinstein LS, Chen M, Xie T, et al.Genetic diseases associated with heterotrimeric G proteins[J].Trends Pharmacol Sci, 2006, 27(5):260-266.[4] Wang JG, Liu L, Zagato L, et al.Blood pressure in relation to three candidate genes in a Chinese population[J].JHypert, 2004, 22(5):937-944.[5] 孙宁玲, 王静毅, 师淑敏.原发性高血压的免疫遗传学研究的探讨[J].中国循环杂志, 1994, 9(12):739-741.[6] 辛培玲, 张强.原发性高血压的免疫学状态[J].医学综述, 1997, 3(12):576-578.[7] 王红英, 邢建新, 马海梅.HLA 基因与原发性高血压的相关性研究[J].中国慢性病预防与控制, 2008, 16(1):108-109.[8] 杜志澎.原发性高血压与脂肪肝及血脂相关性调查[J].中国心血管病研究, 2013, 11(10):758-761.[9] 魏东.原发性高血压患者血压变异性与血脂的相关性研究[J].中国医学创新, 2014, 11(5):103-105.[10] Kwang KK, Seung HH, Michael JQ.Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia [J].Diabetes Care, 2005, 28(6):1419-1424.[11] Brigadeau F, Gelé P, Wibaux M.The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy [J].J Cardiovasc Pharmacol, 2007, 49(6):408-415.[12] 熊正英, 唐量, 战旗.半胱氨酸对训练小鼠力竭运动后不同组织自由基代谢和血清转氨酶活性的影响[J].中国运动医学杂志, 2002, 21(2):170-172.[13] 陈述, 范亚, 杨颖, 等.基于表面富Cd2+的硫化镉量子点荧光增强测定半胱氨酸[J].分析化学, 2012, 40(1):173-176.[14] 黄卫卫, 周小红, 张力华.高血压病免疫机制的研究[J].华中医学杂志, 2003, 27(3):162-163.[15] Luque Otero M, Martell Claros N, Llorente Pérez L, et al.Severe hypertension in the Spanish population.Association with specific HLA antigens [J].Hypertension, 1983, 5(6):149-152. |